Weight & Health Management Industry News

Need More Information On This Industry?

See It All Now! Free Trial

866-704-3389

Weight & Health Management Industry News

Immucor to Present at the Piper Jaffray 21st Annual Health Care Conference (4:23:00pm Mon Nov. 23, 2009 CDT)

NORCROSS, Ga., Nov. 23 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that access to its presentation at the Piper Jaffray 21st Annual Health Care Conference in New York, NY will be available via a live, simultaneous webcast. ...

Boston Scientific to Participate in Piper Jaffray Health Care Conference (4:01:00pm Mon Nov. 23, 2009 CDT)

NATICK, Mass., Nov. 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, December 1-2. ...

YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA (4:00:00pm Mon Nov. 23, 2009 CDT)

MISSISSAUGA, ON, Nov. 23 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported that Cytopia (ASX:CYT) has commenced enrollment of a Phase I/II trial evaluating CYT387, a potent, orally-administered JAK1/JAK2 inhibitor. The trial is being conducted at Mayo Clinic in Rochester, Minnesota. A proposal to merge Cytopia into YM has been previously announced and is pending approval by Cytopia shareholders, Australian court and other regulatory approvals. ...

PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend (3:56:00pm Mon Nov. 23, 2009 CDT)

INCLINE VILLAGE, Nev., Nov. 23 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that NASDAQ has established November 27, 2009 as the ex-dividend date for its $200 million special dividend to stockholders resulting from the securitization transaction completed on November 2, 2009. The dividend will be paid on December 15, 2009 to all stockholders of record on the record date, December 1, 2009. NASDAQ has set the approximate per share amount of the dividend at $1.67 per share of common stock for purposes of the ex-dividend date on November 27, 2009. This approximate per share amount is based on the number of shares of the Company's common stock outstanding on September 30, 2009. ...

New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology (3:44:00pm Mon Nov. 23, 2009 CDT)

WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) and Scholastic, the global children's publishing, education, and media company, are launching "Explore the Mystery of Blood," a dynamic science curriculum designed to spark interest in the fields of science and medicine, in addition to exposing students to exciting career opportunities in hematology. ...

NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference (3:30:00pm Mon Nov. 23, 2009 CDT)

SAN DIEGO, Nov. 23 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Alex Lukianov, Chairman and Chief Executive Officer, and Michael J. Lambert, Executive Vice President and Chief Financial Officer, are scheduled to present at the 21st Annual Piper Jaffray Health Care Conference at the New York Palace in New York, New York, on Wednesday, December 2, 2009, at 10:00 a.m. ET. Mr. Lukianov and Mr. Lambert are also scheduled to present at the J.P. Morgan SMid Cap Conference at the J.P. Morgan Conference Center at 383 Madison Avenue in New York, New York, on Thursday, December 3, 2009, at 1:30 p.m. ET. ...

Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference (3:27:00pm Mon Nov. 23, 2009 CDT)

SUNNYVALE, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the 21st Annual Piper Jaffray Healthcare Conference in New York on Tuesday, December 1, 2009 at 9:00 a.m. ET/6:00 a.m. PT. The company will also present at the J. P. Morgan Small/Mid Cap Conference in New York on Thursday, December 3, 2009 at 3:00 p.m. ET/12:00 p.m. PT. ...

Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties (3:18:00pm Mon Nov. 23, 2009 CDT)

Clinics Continue to Target Individuals in the Recommended Priority Groups ...

DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference (3:15:00pm Mon Nov. 23, 2009 CDT)

CUPERTINO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Matt Hogan, Chief Financial Officer, and Joe Stauffer, Chief Medical Officer, will be presenting at the 21st Annual Piper Jaffray Health Care Conference on Tuesday, December 1 at 3:30 pm Eastern Time. The conference is being held at the New York Palace Hotel in New York City. ...

Pennsylvania Agriculture Department Encourages Proper Food Handling, Offers Safety Tips for Thanksgiving (3:10:00pm Mon Nov. 23, 2009 CDT)

Acting Secretary Encourages Use of PA Preferred Products in Holiday Meals ...

Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services (3:10:00pm Mon Nov. 23, 2009 CDT)

HATBORO, Pa., Nov. 23 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that Jim Way, former Vice President of Managed Services at Siemens Health Services, has joined InfoLogix as Vice President of Strategic Healthcare Services. ...

Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter (3:05:00pm Mon Nov. 23, 2009 CDT)

POINT RICHMOND, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form. The NDA seeks approval to market Intermezzo® for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep. ...

Noted Diagnostic Radiologists Joan Werber, D.O., Ahmed Farag, M.D., C.M., Join Forces to Create Diagnostic Imaging Specialists of Chicago (3:05:00pm Mon Nov. 23, 2009 CDT)

CHICAGO, Nov. 23 /PRNewswire/ -- Two of the Chicago area's leading Board Certified Diagnostic Radiologists are introducing a new era in women's breast imaging, coupling the latest technology in digital mammography, bone density and diagnostic ultrasound with the ability to have the full range of digital imaging completed, diagnosed and discussed with the patient before she leaves the office. Drs. Ahmed Farag and Joan Werber are delivering this patient-friendly approach, without the current 6-9 month wait for an appointment commonly found in Chicago, from their new offices at 60 East Delaware Place, Suite 1410. ...

West Announces Management Change (3:05:00pm Mon Nov. 23, 2009 CDT)

LIONVILLE, Pa., Nov. 23 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the company's Chief Operating Officer Matthew T. Mullarkey has left the company by mutual agreement. Company President and former Chief Operating Officer Steven A. Ellers, 58, will defer his previously announced 2010 retirement in order to provide managerial continuity and support following Mr. Mullarkey's departure. ...

Kaiser Permanente Medicare Plan Ranks Number 1 on 'America's Best Health Insurance Plans' (3:03:00pm Mon Nov. 23, 2009 CDT)

OAKLAND, Calif., Nov. 23 /PRNewswire/ -- Kaiser Permanente has the top-ranked Medicare health plan in the nation, according to a joint ranking by U.S. News & World Report and the National Committee for Quality Assurance. The December 2009 issue, "America's Best Health Insurance Plans 2009-10," ranked the nation's top commercial, Medicare, and Medicaid health plans based on clinical quality data, member satisfaction and NCQA accreditation scores. The announcement comes as beneficiaries review their choices for the Medicare Annual Election Period, which runs through Dec. 31. ...

Register for a Free Trial Now!

Call (866) 704-3389 to get started, or fill out this form and we'll contact you to set up your custom trial. Calling from outside the US?

All fields required.